● Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Condition: Non-Hodgkin Lymphoma · Sponsor: Hoffmann-La Roche

PhasePhase 1

Planned participants121

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 and/or CC-99282) in participants with B-cell NHL.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: CO43805 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (26)

UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program	San Francisco, California, United States	Recruiting
University of Colorado	Aurora, Colorado, United States	Recruiting
Moffitt Cancer Center	Tampa, Florida, United States	Recruiting
The University of Chicago	Chicago, Illinois, United States	Recruiting
Levine Cancer Institute	Charlotte, North Carolina, United States	Recruiting
UT MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Soroka	Beersheba, Israel	Recruiting
Rambam Health Care Campus	Haifa, Israel	Recruiting
Hadassah University Hospital - Ein Kerem	Jerusalem, Israel	Recruiting
Center Hospital	Ramat Gan, Israel	Recruiting
Sourasky Medical Center	Tel Aviv, Israel	Recruiting
IRCCS Azienda Ospedaliero Universitaria di Bologna	Bologna, Emilia-Romagna, Italy	Recruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05169515